<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" nameag="viewport"/>
<title>Male And Female Genital Tract</title>
<script src="https://cdn.tailwindcss.com"></script>
<script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
<script src="https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js"></script>
<style>
        /* Custom styles for enhanced aesthetics and responsiveness */
        .option-btn {
            transition: all 0.3s ease;
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
        }
        .option-btn:hover, .option-btn:active {
            transform: scale(1.02);
            box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
        }
        .option-btn.selected {
            background-color: #3b82f6;
            color: white;
        }
        .marked {
            background-color: #fef08a;
        }
        .progress-bar {
            transition: width 0.5s ease-in-out;
            background: linear-gradient(to right, #3b82f6, #22c55e);
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
            animation: pulse 2s infinite;
        }
        @keyframes pulse {
            0% { opacity: 1; }
            50% { opacity: 0.8; }
            100% { opacity: 1; }
        }
        .question-nav-btn, .result-nav-btn-grid {
            width: 40px;
            height: 40px;
            display: flex;
            align-items: center;
            justify-content: center;
            border-radius: 8px;
            font-size: 16px;
            touch-action: manipulation;
            transition: all 0.2s ease;
        }
        .question-nav-btn:hover, .question-nav-btn:active, .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
            transform: scale(1.05);
        }
        .answered {
            background-color: #22c55e;
            color: white;
        }
        .unanswered {
            background-color: #e5e7eb;
        }
        .marked-nav {
            border: 2px solid #fef08a;
        }
        .video-container, .audio-container {
            display: none;
            position: relative;
        }
        .video-container.active, .audio-container.active {
            display: block;
            animation: fadeIn 0.5s ease-in;
        }
        @keyframes fadeIn {
            from { opacity: 0; }
            to { opacity: 1; }
        }
        .section-transition {
            transition: opacity 0.3s ease;
        }
        .section-transition.hidden {
            opacity: 0;
            pointer-events: none;
        }
        .result-nav {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-top: 1rem;
        }
        .result-nav-btn {
            background-color: #4b5563;
            color: white;
            padding: 0.5rem 1rem;
            border-radius: 8px;
            transition: all 0.2s ease;
        }
        .result-nav-btn:hover, .result-nav-btn:active {
            background-color: #374151;
            transform: scale(1.05);
        }
        .result-nav-btn:disabled {
            background-color: #d1d5db;
            cursor: not-allowed;
        }
        .error-message {
            color: #dc2626;
            font-weight: bold;
            margin-top: 1rem;
        }
        /* Mobile-specific adjustments */
        @media (max-width: 640px) {
            .question-nav-btn, .result-nav-btn-grid {
                width: 38px;
                height: 38px;
                font-size: 14px;
            }
            .nav-panel, .results-nav-panel {
                width: 100%;
                max-width: 100%;
                overscroll-behavior: contain;
            }
            .option-btn {
                padding: 12px;
                font-size: 14px;
            }
            .header-text {
                font-size: 1.5rem;
            }
            .subheader-text {
                font-size: 0.875rem;
            }
            .button-group, .result-nav {
                flex-direction: column;
                gap: 0.5rem;
            }
            .result-nav-btn {
                width: 100%;
                text-align: center;
            }
        }
        /* Dark mode styles */
        .dark .bg-gray-100 {
            background-color: #1f2937;
        }
        .dark .bg-white {
            background-color: #374151;
        }
        .dark .text-gray-700 {
            color: #d1d5db;
        }
        .dark .text-gray-800 {
            color: #e5e7eb;
        }
        .dark .bg-gray-200 {
            background-color: #4b5563;
        }
        .dark .border {
            border-color: #4b5563;
        }
        .dark .bg-blue-500 {
            background-color: #2563eb;
        }
        .dark .hover\:bg-blue-600:hover {
            background-color: #1d4ed8;
        }
        .dark .bg-yellow-300 {
            background-color: #b45309;
            color: white;
        }
        .dark .hover\:bg-yellow-400:hover {
            background-color: #92400e;
        }
        .dark .bg-green-500 {
            background-color: #15803d;
        }
        .dark .hover\:bg-green-600:hover {
            background-color: #166534;
        }
        .dark .bg-gray-500 {
            background-color: #4b5563;
        }
        .dark .hover\:bg-gray-600:hover {
            background-color: #374151;
        }
        .dark .result-nav-btn, .dark .result-nav-btn-grid {
            background-color: #2563eb;
        }
        .dark .result-nav-btn:hover, .dark .result-nav-btn:active, .dark .result-nav-btn-grid:hover, .dark .result-nav-btn-grid:active {
            background-color: #1d4ed8;
        }
        .dark .result-nav-btn:disabled, .dark .result-nav-btn-grid:disabled {
            background-color: #4b5563;
        }
        .video-placeholder {
            width: 400px;
            height: 300px;
            background-color: #f0f0f0;
            display: flex;
            align-items: center;
            justify-content: center;
            cursor: pointer;
            margin-top: 10px;
            border-radius: 8px;
            border: 1px solid #ccc;
        }
        .play-icon {
            font-size: 40px;
            color: #007bff;
        }
        .video-loading {
            position: absolute;
            top: 50%;
            left: 50%;
            transform: translate(-50%, -50%);
            border: 4px solid #f3f3f3;
            border-top: 4px solid #3b82f6;
            border-radius: 50%;
            width: 40px;
            height: 40px;
            animation: spin 1s linear infinite;
        }
        @keyframes spin {
            0% { transform: translate(-50%, -50%) rotate(0deg); }
            100% { transform: translate(-50%, -50%) rotate(360deg); }
        }
    </style>

<script>
    // --- GEMINI AUTO-CAPTURE LISTENER ---
    // This function runs immediately after the quiz determines an answer is INCORRECT.
    function captureMistake(questionIndex, questionsData) {
        try {
            const item = questionsData[questionIndex];
            // Use the question text as a unique, stable identifier
            const uniqueId = 'srs_quiz_' + btoa(item.text.substring(0, 50)).replace(/=/g, ''); 

            // 1. Clean and simplify the explanation for storage
            let explanationText = item.explanation || item.correct_answer || "No explanation provided.";
            
            // Strip complex HTML (images, lists) and boilerplate text
            explanationText = explanationText.replace(/<img[^>]*>/g, "[IMAGE]").trim(); // Replace images with placeholder
            explanationText = explanationText.replace(/<p><strong>Ans\. [A-Z]\).*/i, "").trim(); // Remove the repeated Answer line
            explanationText = explanationText.replace(/<p><strong>Educational Objective:<\/strong>.*?<\/p>/gs, "").trim(); // Remove EO block
            explanationText = explanationText.replace(/@dams_new_robot/g, "");
            explanationText = explanationText.replace(/<\/?[^>]+(>|$)/g, " ").trim(); // Final strip of remaining tags

            // 2. Prepare card data
            const cardData = {
                text: item.text,
                answer: item.correct_answer,
                explanation: explanationText.substring(0, 500), // Keep explanations short
                nextReview: 0, // Due immediately
                reviews: 0,
                source: document.title.split('-')[0].trim() || 'Quiz'
            };

            // 3. Save to Local Storage (SRS Bank)
            localStorage.setItem(uniqueId, JSON.stringify(cardData));
            
            console.log(`ðŸ§  Captured Mistake #${questionIndex + 1} from ${document.title}`);

        } catch (e) {
            console.error("SRS Capture Failed:", e);
        }
    }
    // --- END GEMINI AUTO-CAPTURE LISTENER ---
</script>

</head>
<body class="bg-gray-100 font-sans transition-colors duration-300 min-h-screen overflow-y-auto">
<!-- Header Section -->
<header class="bg-blue-600 text-white p-4 shadow-lg">
<div class="container mx-auto">
<h1 class="text-2xl md:text-3xl font-bold header-text">Male And Female Genital Tract</h1>
<p class="mt-2 text-sm md:text-base subheader-text">
                36 Questions | 144 Total Marks | 46 min Duration | ~76.67 sec/question
            </p>
<button class="mt-2 bg-gray-200 text-gray-800 px-3 py-1 rounded-lg hover:bg-gray-300 transition dark:bg-gray-600 dark:text-white" id="theme-toggle">
                Toggle Dark Mode
            </button>
</div>
</header>
<!-- Instructions Section -->
<section class="container mx-auto p-4 md:p-6 section-transition" id="instructions">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-xl font-semibold mb-4">Instructions</h2>
<ul class="list-disc list-inside space-y-2 text-gray-700">
<li>This test contains 36 multiple choice questions.</li>
<li>Each question has only one correct answer.</li>
<li>You will have 46 minutes to complete the test.</li>
<li>Click or tap on an option to select your answer.</li>
<li>Use the "Mark for Review" button to revisit questions.</li>
<li>Navigate using Previous/Next buttons or the Questions Navigation panel.</li>
<li>Click "Submit" to finish and view results.</li>
<li>The test will auto-submit when time runs out.</li>
</ul>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="start-test">Start Test</button>


</div>
<div class="error-message hidden" id="error-message"></div>
</div>
</section>
<!-- Quiz Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="quiz">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<!-- Progress Bar -->
<div class="w-full bg-gray-200 rounded-full h-3 mb-4">
<div class="progress-bar h-3 rounded-full" id="progress-bar" style="width: 0%"></div>
</div>
<!-- Question Header -->
<div class="flex flex-col md:flex-row justify-between items-center mb-4">
<h2 class="text-lg font-semibold" id="question-number">Question <span>1</span> of 36</h2>
<p class="text-lg font-semibold mt-2 md:mt-0" id="timer">Time Remaining: <span>00:00</span></p>
</div>
<!-- Question Content -->
<div class="mb-6" id="question-content">
<p class="text-gray-800 mb-4" id="question-text"></p>
<div class="flex flex-wrap gap-4 mb-4" id="question-images"></div>
<div class="space-y-3" id="options"></div>
</div>
<!-- Navigation Buttons -->
<div class="flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition w-full md:w-auto" disabled="" id="previous-btn">Previous</button>
<button class="bg-yellow-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-yellow-400 transition w-full md:w-auto" id="mark-review">Mark for Review</button>
<button class="bg-blue-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="next-btn">Next</button>
<button class="bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full md:w-auto" id="nav-toggle">Questions Navigation</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="submit-test">Submit Test</button>
</div>
</div>
</section>
<!-- Results Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="results">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-2xl font-semibold mb-4">Male And Female Genital Tract - Results</h2>
<div class="grid grid-cols-1 md:grid-cols-2 gap-4 mb-6">
<p><strong>Correct:</strong> <span id="correct-count">0</span></p>
<p><strong>Wrong:</strong> <span id="wrong-count">0</span></p>
<p><strong>Unanswered:</strong> <span id="unanswered-count">0</span></p>
<p><strong>Marked for Review:</strong> <span id="marked-count">0</span></p>
</div>
<h3 class="text-lg font-semibold mb-4" id="result-question-number">Question <span>1</span> of 36</h3>
<div class="space-y-6" id="results-content"></div>
<div class="result-nav">
<button aria-label="Previous question result" class="result-nav-btn" disabled="" id="prev-result">Previous</button>
<button aria-label="Toggle results navigation panel" class="result-nav-btn" id="results-nav-toggle">Results Navigation</button>
<button aria-label="Next question result" class="result-nav-btn" id="next-result">Next</button>
</div>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="take-again">Take Again</button>
<button class="bg-gray-500 text-white px-6 py-2 rounded-lg hover:bg-gray-600 transition" id="review-test">Review Test</button>
</div>
</div>
</section>
<!-- Exit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="exit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Leave Test?</h2>
<p class="text-gray-700 mb-4">Your progress will be lost if you leave this page. Are you sure you want to exit?</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="continue-test">No, Continue</button>
<button class="bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition" id="exit-test">Yes, Exit</button>
</div>
</div>
</div>
<!-- Submit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="submit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Confirm Submission</h2>
<p class="text-gray-700 mb-2">You have attempted <span id="attempted-count">0</span> of 36 questions.</p>
<p class="text-gray-700 mb-4"><span id="unattempted-count">0</span> questions are unattempted.</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="cancel-submit">Cancel</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-green-600 transition" id="confirm-submit">Submit Test</button>
</div>
</div>
</div>
<!-- Quiz Navigation Panel -->
<div class="fixed inset-y-0 right-0 nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="nav-panel">
<h2 class="text-lg font-semibold mb-4">Questions Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-nav">Close</button>
</div>
<!-- Results Navigation Panel -->
<div class="fixed inset-y-0 right-0 results-nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="results-nav-panel">
<h2 class="text-lg font-semibold mb-4">Results Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="results-nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="results-nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-results-nav">Close</button>
</div>
<!-- JavaScript Logic -->
<script>
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog("Attempting to parse questions_json");
            questions = [{"text": "A 25-year-old female presents with abdominal pain and a pelvic mass. Histological examination of the ovarian tumor reveals the presence of Schiller-Duval bodies. Which of the following is the most likely diagnosis?", "options": [{"label": "A", "text": "Dysgerminoma", "correct": false}, {"label": "B", "text": "Teratoma", "correct": false}, {"label": "C", "text": "Yolk sac tumor", "correct": true}, {"label": "D", "text": "Granulosa cell tumor", "correct": false}], "correct_answer": "C. Yolk sac tumor", "question_images": [], "explanation_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/23/screenshot-2024-04-23-160557.png"], "explanation": "<p><strong>Ans. C) Yolk sac tumor</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation:</li><li>â€¢ Option A . Dysgerminoma are type of ovarian germ cell tumor , but they are characterized by monotonous sheets of large , undifferentiated cells resembling primordial germ cells .</li><li>â€¢ Option</li><li>â€¢ A</li><li>â€¢ Dysgerminoma</li><li>â€¢ ovarian germ cell tumor</li><li>â€¢ monotonous sheets of large</li><li>â€¢ undifferentiated cells</li><li>â€¢ primordial germ cells</li><li>â€¢ Option B . Teratoma are composed of multiple germ cell layers and can contain a variety of tissues such as epithelium, hair , and cartilage .</li><li>â€¢ Option</li><li>â€¢ B</li><li>â€¢ Teratoma</li><li>â€¢ composed of multiple germ cell layers</li><li>â€¢ contain a variety of tissues</li><li>â€¢ epithelium, hair</li><li>â€¢ cartilage</li><li>â€¢ Option D . Granulosa cell tumors are sex cord-stromal tumors , and they are characterized by the presence of Call-Exner bodies . These bodies are small, eosinophilic fluid-filled spaces surrounded by granulosa cells.</li><li>â€¢ Option</li><li>â€¢ D</li><li>â€¢ Granulosa cell tumors</li><li>â€¢ sex cord-stromal tumors</li><li>â€¢ presence of Call-Exner bodies</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ The presence of Schiller-Duval bodies in an ovarian mass biopsy is pathognomonic for yolk sac tumors , also known as endodermal sinus tumors , and is the most likely diagnosis in a young woman presenting with these histological findings.</li><li>âž¤ presence of Schiller-Duval bodies</li><li>âž¤ ovarian mass biopsy</li><li>âž¤ pathognomonic for yolk sac tumors</li><li>âž¤ endodermal sinus tumors</li><li>âž¤ young woman</li><li>âž¤ Ref : Robbins 10 th 1025</li><li>âž¤ Ref</li><li>âž¤ : Robbins 10 th 1025</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 30-year-old male was investigated for infertility. Semen analysis revealed azoospermia and biopsy was taken which is shown in the image. What is the likely diagnosis in the patient?", "options": [{"label": "A", "text": "Orchitis", "correct": false}, {"label": "B", "text": "Sertoli cell only tumor", "correct": true}, {"label": "C", "text": "Testicular atrophy", "correct": false}, {"label": "D", "text": "Non-seminomatous germ cell tumor", "correct": false}], "correct_answer": "B. Sertoli cell only tumor", "question_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/28/untitled-546.jpg"], "explanation_images": [], "explanation": "<p><strong>Ans. B) Sertoli cell only tumor</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation;</li><li>â€¢ Option A. Orchitis usually presents with signs of inflammation, not solely with the absence of germ cells as in the biopsy image.</li><li>â€¢ Option A.</li><li>â€¢ Orchitis</li><li>â€¢ Option C . Testicular atrophy involves shrinkage and decreased cellular density in the seminiferous tubules, ofte accompanied by fibrosis, which is not demonstrated in the biopsy provided.</li><li>â€¢ Option C</li><li>â€¢ Testicular atrophy</li><li>â€¢ Option D . Non-seminomatous germ cell tumors typically display malignant cells with various histologic patterns, which are not evident in the biopsy image.</li><li>â€¢ Option D</li><li>â€¢ Non-seminomatous germ cell tumors</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Sertoli cell only syndrome, also known as germ cell aplasia, is diagnosed when testicular biopsy reveals seminiferous tubules with only Sertoli cells and an absence of germ cells, correlating with clinical findings of azoospermia and infertility in a male patient.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 35-year-old woman undergoes a breast biopsy after a suspicious mammogram. Histological examination reveals a tumor with lack of tubule formation, discohesive cells and a low mitotic rate. Immunohistochemistry shows positive estrogen receptor (ER) and progesterone receptor (PR) staining. What is the most likely histological type of breast cancer?", "options": [{"label": "A", "text": "Invasive ductal carcinoma", "correct": false}, {"label": "B", "text": "Invasive lobular carcinoma", "correct": true}, {"label": "C", "text": "Medullary carcinoma", "correct": false}, {"label": "D", "text": "Ductal carcinoma in situ (DCIS)", "correct": false}], "correct_answer": "B. Invasive lobular carcinoma", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. B) Invasive lobular carcinoma</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation:</li><li>â€¢ Option A. Invasive ductal carcinoma tends to form glandular structures and does not usually present with the \"Indian file\" pattern of cell arrangement seen in invasive lobular carcinoma.</li><li>â€¢ Option A.</li><li>â€¢ Invasive ductal carcinoma</li><li>â€¢ glandular structures</li><li>â€¢ Option C. Medullary carcinoma has a higher mitotic rate and a lymphocytic infiltrate , which differs from the low mitotic rate and discohesive cells described in the biopsy report.</li><li>â€¢ Option C.</li><li>â€¢ Medullary carcinoma</li><li>â€¢ higher mitotic rate</li><li>â€¢ lymphocytic infiltrate</li><li>â€¢ Option D . Ductal carcinoma in situ represents an early form of breast cancer that is confined to the ducts and usually forms duct-like structures, unlike the pattern described.</li><li>â€¢ Option D</li><li>â€¢ Ductal carcinoma</li><li>â€¢ in situ</li><li>â€¢ early form of breast cancer</li><li>â€¢ confined to the ducts</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Invasive lobular carcinoma is characterized by the absence of tubule formation , discohesive cells , a low mitotic rate , and positive hormone receptor status .</li><li>âž¤ Invasive lobular carcinoma</li><li>âž¤ absence of tubule formation</li><li>âž¤ discohesive cells</li><li>âž¤ low mitotic rate</li><li>âž¤ positive hormone receptor status</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 47-year-old woman presents for evaluation of a hard, poorly defined mass in her left breast. She reports no pain or discharge, but she has noted a recent change in the shape of the breast. There is no family history of breast cancer. A mammogram reveals microcalcifications in the upper outer quadrant of the left breast. A biopsy of the lesion is performed. The type of mammary ductal carcinoma in situ (DCIS) most likely to result in a palpable abnormality in the breast is:", "options": [{"label": "A", "text": "Apocrine DCIS", "correct": false}, {"label": "B", "text": "Neuroendocrine DCIS", "correct": false}, {"label": "C", "text": "Will-differentiated DCIS", "correct": false}, {"label": "D", "text": "Comedo DCIS", "correct": true}], "correct_answer": "D. Comedo DCIS", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. D) Comedo DCIS</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation:</li><li>â€¢ Option A. Apocrine DCIS presents with characteristic apocrine cytologic features under microscopy but is not the most likely to form a palpable mass.</li><li>â€¢ Option A.</li><li>â€¢ Apocrine DCIS</li><li>â€¢ characteristic apocrine cytologic features under microscopy</li><li>â€¢ Option B. Neuroendocrine DCIS is a rare form and typically does not present as a palpable lesion in the breast.</li><li>â€¢ Option B.</li><li>â€¢ Neuroendocrine DCIS</li><li>â€¢ rare form</li><li>â€¢ Option C. Well-differentiated DCIS may show microcalcifications on mammography , but palpable masses are less common than in the comedo subtype.</li><li>â€¢ Option C.</li><li>â€¢ Well-differentiated DCIS</li><li>â€¢ show microcalcifications</li><li>â€¢ mammography</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Comedo DCIS is most likely to present as a palpable mass due to the associated necrosis and calcifications . It is often found on mammography and can form a more solid , palpable lesion compared to other subtypes of DCIS.</li><li>âž¤ Comedo DCIS</li><li>âž¤ present as a palpable mass</li><li>âž¤ associated necrosis</li><li>âž¤ calcifications</li><li>âž¤ found on mammography</li><li>âž¤ form a more solid</li><li>âž¤ palpable lesion</li><li>âž¤ Ref : Robbins 10 th 1060</li><li>âž¤ Ref</li><li>âž¤ : Robbins 10 th 1060</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "BRCA 1 gene is located on:", "options": [{"label": "A", "text": "Chromosome 13", "correct": false}, {"label": "B", "text": "Chromosome 11", "correct": false}, {"label": "C", "text": "Chromosome 17", "correct": true}, {"label": "D", "text": "Chromosome 22", "correct": false}], "correct_answer": "C. Chromosome 17", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. C) Chromosome 17</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation</li><li>â€¢ :</li><li>â€¢ Tumor-suppressor gene , BRCA-1 (17q21) encodes a zinc finger protein , and the product therefore may function as a transcription factor. The gene appears to be involved in gene repair . BRCA-2 (13q12) is also associated with an increased incidence of breast cancer in men and women .</li><li>â€¢ Tumor-suppressor gene , BRCA-1 (17q21) encodes a zinc finger protein , and the product therefore may function as a transcription factor. The gene appears to be involved in gene repair .</li><li>â€¢ Tumor-suppressor gene</li><li>â€¢ BRCA-1</li><li>â€¢ encodes</li><li>â€¢ zinc finger protein</li><li>â€¢ product</li><li>â€¢ involved in gene repair</li><li>â€¢ BRCA-2 (13q12) is also associated with an increased incidence of breast cancer in men and women .</li><li>â€¢ BRCA-2</li><li>â€¢ associated with an increased incidence of breast cancer</li><li>â€¢ men and women</li><li>â€¢ Educational objective :</li><li>â€¢ Educational objective</li><li>â€¢ :</li><li>â€¢ BRCA 1 gene is located on Chromosome 17q and BRCA2 gene is located on chromosome 13q.</li><li>â€¢ BRCA 1 gene</li><li>â€¢ Chromosome 17q</li><li>â€¢ BRCA2 gene</li><li>â€¢ chromosome 13q.</li><li>â€¢ Ref : Robbin 10 th / 1045</li><li>â€¢ Ref</li><li>â€¢ : Robbin 10 th / 1045</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Increased susceptibility to sporadic breast cancer is likely to be associated with a mutation in the following gene?", "options": [{"label": "A", "text": "p53", "correct": true}, {"label": "B", "text": "BRCA-1", "correct": false}, {"label": "C", "text": "Retinoblastoma (Rb)", "correct": false}, {"label": "D", "text": "H-Ras", "correct": false}], "correct_answer": "A. p53", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. A) p53</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation</li><li>â€¢ :</li><li>â€¢ Option B. The BRCA1 gene mutation carries a high risk for developing breast and ovarian cancers . Individuals with this mutation have a lifetime risk of breast cancer that is significantly higher than the general population.</li><li>â€¢ Option B.</li><li>â€¢ BRCA1 gene mutation</li><li>â€¢ high risk for developing breast</li><li>â€¢ ovarian cancers</li><li>â€¢ Option C . While the Rb gene is crucial in controlling cell proliferation and its mutation is primarily associated with retinoblastoma , it is not a leading cause of breast cancer.</li><li>â€¢ Option C</li><li>â€¢ Rb gene</li><li>â€¢ controlling cell proliferation</li><li>â€¢ mutation</li><li>â€¢ associated with retinoblastoma</li><li>â€¢ Option D . H-Ras is part of the Ras gene family ; while mutations in these genes can lead to cancer , they are not typically associated with hereditary breast cancer syndromes.</li><li>â€¢ Option D</li><li>â€¢ H-Ras</li><li>â€¢ part of the Ras gene family</li><li>â€¢ mutations</li><li>â€¢ genes can lead to cancer</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ The p53 gene mutation is the most important gene mutation increasing susceptibility to breast cancer .</li><li>âž¤ p53 gene mutation</li><li>âž¤ most important gene mutation increasing susceptibility</li><li>âž¤ breast cancer</li><li>âž¤ Ref : Robbins 10 th 1051</li><li>âž¤ Ref : Robbins 10 th 1051</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A female patient presented with a firm mass of 2 Ã— 2 cm in the upper outer quadrant of the breast. She gives a family history of ovarian carcinoma. The investigation that needs to be done to assess for mutations is:", "options": [{"label": "A", "text": "p53", "correct": false}, {"label": "B", "text": "BRCA-2", "correct": true}, {"label": "C", "text": "Her 2/Neu gene", "correct": false}, {"label": "D", "text": "C-myc gene", "correct": false}], "correct_answer": "B. BRCA-2", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. B) BRCA2</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation:</li><li>â€¢ Option A. The p53 gene , when mutated , can lead to a variety of cancers ; however, in the context of a family history suggesting a hereditary breast and ovarian cancer syndrome, BRCA1 and BRCA2 gene testing is more directly relevant.</li><li>â€¢ Option A.</li><li>â€¢ The p53 gene</li><li>â€¢ mutated</li><li>â€¢ variety of cancers</li><li>â€¢ Option C . Her 2/Neu gene amplification is associated with breast cancer aggressiveness and treatment decisions but is not a part of routine genetic screening for hereditary breast and ovarian cancer syndrome.</li><li>â€¢ Option C</li><li>â€¢ Her 2/Neu gene</li><li>â€¢ associated with breast cancer aggressiveness</li><li>â€¢ treatment decisions</li><li>â€¢ Option D. C-myc is an oncogene implicated in the pathogenesis of various cancers , including breast cancer , but it does not have a direct role in hereditary breast and ovarian cancer syndromes.</li><li>â€¢ Option D.</li><li>â€¢ C-myc</li><li>â€¢ oncogene implicated</li><li>â€¢ pathogenesis of various cancers</li><li>â€¢ breast cancer</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ BRCA2 genetic testing is indicated in a patient with a breast mass and a family history of ovarian carcinoma , as mutations in the BRCA1 and BRCA2 genes are strongly associated with hereditary breast and ovarian cancer syndromes .</li><li>âž¤ BRCA2 genetic testing</li><li>âž¤ breast mass</li><li>âž¤ family history of ovarian carcinoma</li><li>âž¤ mutations</li><li>âž¤ BRCA1 and BRCA2 genes</li><li>âž¤ hereditary breast</li><li>âž¤ ovarian cancer syndromes</li><li>âž¤ Ref : Robbins 10 th 1058</li><li>âž¤ Ref</li><li>âž¤ : Robbins 10 th 1058</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "All invasive breast carcinomas are graded histologically with the following scoring system:", "options": [{"label": "A", "text": "Nottingham", "correct": true}, {"label": "B", "text": "Birmingham", "correct": false}, {"label": "C", "text": "Cunningham", "correct": false}, {"label": "D", "text": "Welham", "correct": false}], "correct_answer": "A. Nottingham", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. A) Nottingham</strong></p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 55-year-old woman presents with a suspicious breast mass. A core biopsy is performed, and immunohistochemistry (IHC) reveals a HER2/neu score of 2. Given the equivocal HER2 status, which technique is most appropriate for further evaluation to determine the HER2/neu gene amplification status?", "options": [{"label": "A", "text": "Polymerase Chain Reaction (PCR)", "correct": false}, {"label": "B", "text": "Fluorescence In Situ Hybridization (FISH)", "correct": true}, {"label": "C", "text": "Southern Blotting", "correct": false}, {"label": "D", "text": "Western Blotting", "correct": false}], "correct_answer": "B. Fluorescence In Situ Hybridization (FISH)", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation:</li><li>â€¢ Option A. Polymerase Chain Reaction (PCR ) is a technique used to amplify DNA but is not typically employed to assess gene amplification status. It is more suitable for studying the presence or absence of specific DNA sequences.</li><li>â€¢ Option A. Polymerase Chain Reaction (PCR</li><li>â€¢ technique</li><li>â€¢ amplify DNA</li><li>â€¢ Option C. Southern blotting is a technique used to detect specific DNA sequences in a DNA sample .</li><li>â€¢ Option C. Southern blotting</li><li>â€¢ detect specific DNA sequences</li><li>â€¢ DNA sample</li><li>â€¢ Option D. Western blotting is a technique used to detect specific proteins in a sample . It is not applicable to assess gene amplification and is more suited for protein analysis.</li><li>â€¢ Option D. Western blotting</li><li>â€¢ detect specific proteins in a sample</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ In cases of equivocal HER2/neu IHC results which is IHC score of 2 , further recommended technique is Fluorescence In Situ Hybridization (FISH) for evaluation of HER2/neu gene amplification status in breast cancer .</li><li>âž¤ equivocal HER2/neu IHC</li><li>âž¤ IHC score of 2</li><li>âž¤ Fluorescence In Situ Hybridization</li><li>âž¤ HER2/neu gene amplification status</li><li>âž¤ breast cancer</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 45-year-old woman presents with a palpable lump in her left breast. A biopsy is performed, and the histopathological examination reveals invasive ductal carcinoma. Immunohistochemistry (IHC) shows a HER2/neu score of 3+. What is the most appropriate next step in managing this patient